The global Pendred Syndrome (Ps) Market size was estimated at USD 2.82 billion in 2023 and is projected to reach USD 3.83 billion in 2030 at a CAGR of 4.5% during the forecast period 2023-2030.
Pendred syndrome, often abbreviated to PS, is a rare genetic disorder characterized by a combination of sensorineural hearing loss and thyroid dysfunction. It is named after British physician Vaughan Pendred, who first described the syndrome in the early 20th century. Pendred syndrome is caused by mutations in the SLC26A4 gene, also known as the pendrin gene.
Get Free Sample Report@ https://www.delvens.com/get-free-sample/pendred-syndrome-ps-market
The COVID-19 pandemic potentially disrupted the Pendred Syndrome (PS) market by delaying diagnoses, access to treatment and research. Healthcare disruptions, supply chain challenges and changing priorities may have hindered patient care and research. Telehealth adoption has increased, but may not completely replace the need for in-person care.
Key Findings:
The Treatment segment is further fragmented into Cochlear Implant, Hearing Aids, and Radioactive Iodine. The Cochlear Implant segment is expected to account for a larger market size during the forecast period. Cochlear implants are electronic devices that are surgically implanted into the inner ear to provide a sense of sound for individuals with severe to profound hearing loss.
The diagnosis segment is further bifurcated into Genetic Testing, Perchlorate Washout Test, and Others. The Genetic Testing is the largest market during the forecast period. Genetic testing is a crucial tool in diagnosing Pendred Syndrome. This involves analyzing the DNA of an individual to identify mutations in the SLC26A4 gene, which is associated with the syndrome.
Recent Developments
- Biotechnology Companies: Biotechnology companies may focus on advancing gene therapy approaches for Pendred Syndrome. This includes research into gene editing technologies, viral vectors, and delivery mechanisms to correct or replace the faulty SLC26A4 gene in affected individuals.
- Research Institutions and Academia: Academic institutions and research organizations play a significant role in studying rare genetic disorders like Pendred Syndrome. Their contributions may include conducting studies to understand the underlying mechanisms of the disease, exploring potential therapeutic targets, and collaborating with industry partners to translate research findings into clinical applications.
Competitive Landscape
· Nobel pharma Co.,Ltd
· Sensorion
· Advanced Bionics AG
· MED-EL Medical Electronics
· Cochlear Ltd
· Sonova
· GAES and more.
For More Inquiry@ https://www.delvens.com/Inquire-before-buying/pendred-syndrome-ps-market
North America to Dominate the Market
· North America is estimated to account for the largest market share during the forecast period due to rising healthcare costs, increased R & D, and trending technological advancements.
· Moreover, Moreover, growing focus of major key players on further R&D will further propel the market’s growth rate in this region.
The Pendred Syndrome (PS) Market Segmentation:
Based on Treatment
· Cochlear Implant
· Hearing Aids
Based on the Administration
· Oral
· Implantation
Based on the Diagnosis
· Genetic Testing
· Perchlorate Washout Test
Based on End Users
· Hospitals
· Homecare
Based on region:
· Asia Pacific
· North America
· Europe
· South America
· Middle East & Africa
Get Complete Info@ https://www.delvens.com/report/pendred-syndrome-ps-market
Frequently Asked Questions
· What are the years considered to study Pendred Syndrome (PS) Market?
· What is the compound annual growth rate (CAGR) of the Pendred Syndrome (PS) Market?
· Which region holds the largest market share in Pendred Syndrome (PS) Market?
· Which region is the fastest growing in Pendred Syndrome (PS) Market?
· Who are the major players in Pendred Syndrome (PS) Market?
In addition to the market data for the Pendred Syndrome (PS) Market, Delvens offers client-centric reports customized according to the company’s specific demand and requirements.
More Related Reports:
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact us:
Unit No. 01, 3rd Floor, Plot No. 56, Block B
Sector 2 Noida, Near Noida Sector 15 Metro Station 201301, IN
+44 20 3290 6466
+0120- 4903958
Comments
0 comment